miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-05
DOI
10.1038/s41419-019-2164-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP
- (2018) Feng Ding et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation
- (2018) Wei Zhang et al. LABORATORY INVESTIGATION
- miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
- (2018) Jing Sun et al. ONCOGENE
- FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
- (2018) Shaoqiang Cheng et al. CANCER BIOLOGY & THERAPY
- The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- EMT: Present and future in clinical oncology
- (2017) Patricia G. Santamaria et al. Molecular Oncology
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma
- (2017) Ai-Qing Lu et al. ONCOLOGY REPORTS
- MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
- (2017) Qiong Feng et al. Experimental and Therapeutic Medicine
- miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3
- (2017) Ruilin Chen et al. Oncology Letters
- Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met
- (2017) Tao Chen et al. Scientific Reports
- Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism
- (2017) J Dong et al. Oncogenesis
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- Abstract P5-08-22: DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer
- (2016) B Györffy et al. CANCER RESEARCH
- MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion
- (2016) Lanying Sun et al. CELL PROLIFERATION
- Management and Outcomes in Metaplastic Breast Cancer
- (2016) Ioannis-Georgios Tzanninis et al. Clinical Breast Cancer
- The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues
- (2016) Xiu Chen et al. GENE
- A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line
- (2016) Annette Lasham et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Diagnosis and Management of Breast Cancer
- (2016) E. S. McDonald et al. JOURNAL OF NUCLEAR MEDICINE
- Novel miRNA genes hypermethylated in breast cancer
- (2016) V. I. Loginov et al. MOLECULAR BIOLOGY
- miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C
- (2016) Yantao Du et al. TUMOR BIOLOGY
- MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells
- (2016) Min Zhu et al. TUMOR BIOLOGY
- Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles
- (2015) Pengcheng Yu et al. Acta Biomaterialia
- Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
- (2015) JING HUANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Notch1 signaling regulates the epithelial–mesenchymal transition and invasion of breast cancer in a Slug-dependent manner
- (2015) Shan Shao et al. Molecular Cancer
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- Breast cancer stem cells, EMT and therapeutic targets
- (2014) Srishti Kotiyal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dual specificity phosphatase 4 gene expression in association with triple-negative breast cancer outcome
- (2014) Michelle L. Baglia et al. BREAST CANCER RESEARCH AND TREATMENT
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin
- (2013) Yu Liu et al. EXPERIMENTAL CELL RESEARCH
- miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1
- (2012) X. Zhu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
- (2012) Justin M Balko et al. NATURE MEDICINE
- MiR-137 Targets Estrogen-Related Receptor Alpha and Impairs the Proliferative and Migratory Capacity of Breast Cancer Cells
- (2012) Yuanyin Zhao et al. PLoS One
- Emerging Role of MicroRNAs in Drug-Resistant Breast Cancer
- (2011) SARMILA MAJUMDER et al. GENE EXPRESSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More